Amicus Therapeutics (Nasdaq: FOLD) today announced it has commenced a $250 million underwritten public offering of its common stock. J.P ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE